These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25869011)

  • 21. Hematology consult: high-sensitivity warfarin genotype.
    Schwer C; Lamana S; Dasanu CA
    Conn Med; 2013; 77(10):581-5. PubMed ID: 24367840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-guided versus traditional clinical dosing of warfarin in patients of Asian ancestry: a randomized controlled trial.
    Syn NL; Wong AL; Lee SC; Teoh HL; Yip JWL; Seet RC; Yeo WT; Kristanto W; Bee PC; Poon LM; Marban P; Wu TS; Winther MD; Brunham LR; Soong R; Tai BC; Goh BC
    BMC Med; 2018 Jul; 16(1):104. PubMed ID: 29986700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation.
    Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF;
    Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal loading dose for the initiation of warfarin: a systematic review.
    Heneghan C; Tyndel S; Bankhead C; Wan Y; Keeling D; Perera R; Ward A
    BMC Cardiovasc Disord; 2010 Apr; 10():18. PubMed ID: 20403189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic analysis and comparison of warfarin initiation strategies.
    French B; Wang L; Gage BF; Horenstein RB; Limdi NA; Kimmel SE
    Pharmacogenet Genomics; 2016 Oct; 26(10):445-52. PubMed ID: 27383664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype-guided versus standard vitamin K antagonist dosing algorithms in patients initiating anticoagulation. A systematic review and meta-analysis.
    Belley-Cote EP; Hanif H; D'Aragon F; Eikelboom JW; Anderson JL; Borgman M; Jonas DE; Kimmel SE; Manolopoulos VG; Baranova E; Maitland-van der Zee AH; Pirmohamed M; Whitlock RP
    Thromb Haemost; 2015 Oct; 114(4):768-77. PubMed ID: 26158747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing.
    Kasner SE; Wang L; French B; Messe SR; Horenstein R; Mohler ER; Muldowney JA; Ellenberg J; Kimmel SE
    Am J Cardiovasc Drugs; 2015 Aug; 15(4):267-74. PubMed ID: 26037731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International warfarin genotype-guided dosing algorithms in the Turkish population and their preventive effects on major and life-threatening hemorrhagic events.
    Karaca S; Bozkurt NC; Cesuroglu T; Karaca M; Bozkurt M; Eskioglu E; Polimanti R
    Pharmacogenomics; 2015; 16(10):1109-18. PubMed ID: 26216670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-Guided Warfarin Dosing in Patients With Mechanical Valves: A Randomized Controlled Trial.
    Xu Z; Zhang SY; Huang M; Hu R; Li JL; Cen HJ; Wang ZP; Ou JS; Yin SL; Xu YQ; Wu ZK; Zhang X
    Ann Thorac Surg; 2018 Dec; 106(6):1774-1781. PubMed ID: 30205115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II).
    Anderson JL; Horne BD; Stevens SM; Woller SC; Samuelson KM; Mansfield JW; Robinson M; Barton S; Brunisholz K; Mower CP; Huntinghouse JA; Rollo JS; Siler D; Bair TL; Knight S; Muhlestein JB; Carlquist JF
    Circulation; 2012 Apr; 125(16):1997-2005. PubMed ID: 22431865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen.
    Sconce EA; Kamali F
    Eur J Haematol; 2006 Dec; 77(6):457-62. PubMed ID: 17042764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.
    Oskarsdóttir AR; Gudmundsdottir BR; Indridason OS; Lund SH; Arnar DO; Bjornsson ES; Magnusson MK; Jensdottir HM; Vidarsson B; Francis CW; Onundarson PT
    J Thromb Thrombolysis; 2017 May; 43(4):550-561. PubMed ID: 28214948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
    Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
    Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-guided dosing of warfarin through modeling and simulation.
    Deng J; Vozmediano V; Rodriguez M; Cavallari LH; Schmidt S
    Eur J Pharm Sci; 2017 Nov; 109S():S9-S14. PubMed ID: 28502675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.
    Xu H; Xie X; Wang B; Chen Y; Meng T; Ma S; Wang F
    Int J Cardiol; 2014 Dec; 177(2):654-7. PubMed ID: 25449474
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgery population: a prospective, parallel cohort study.
    McMillin GA; Melis R; Wilson A; Strong MB; Wanner NA; Vinik RG; Peters CL; Pendleton RC
    Ther Drug Monit; 2010 Jun; 32(3):338-45. PubMed ID: 20386359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial.
    Schulman S; Parpia S; Stewart C; Rudd-Scott L; Julian JA; Levine M
    Ann Intern Med; 2011 Nov; 155(10):653-9, W201-3. PubMed ID: 22084331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is home warfarin self-management effective? Results of the randomised Self-Management of Anticoagulation Research Trial.
    Dignan R; Keech AC; Gebski VJ; Mann KP; Hughes CF;
    Int J Cardiol; 2013 Oct; 168(6):5378-84. PubMed ID: 24083884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy.
    Nieuwlaat R; Hubers LM; Spyropoulos AC; Eikelboom JW; Connolly BJ; Van Spall HG; Schulze KM; Cuddy SM; Stehouwer AC; Schulman S; Connolly SJ
    Thromb Haemost; 2012 Dec; 108(6):1228-35. PubMed ID: 23015161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
    Meijer K; Kim YK; Carter D; Schulman S
    Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.